Citation Impact
Citing Papers
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
polycystic kidney disease
1990
The Effect of Protein Restriction on the Progression of Renal Insufficiency
1989
Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients
2000
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure
1993
Pathophysiology of Progressive Nephropathies
1998 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
1996 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection
1992
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ
2008
Baseline characteristics of participants in the appropriate blood pressure control in diabetes trial
1996
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
1999 Standout
Prevalence of hypertension in 1,795 subjects with chronic renal disease: The modification of diet in renal disease study baseline cohort
1996
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
The modification of diet in renal disease study group
1991
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Calcium oxalate nephrolithiasis: Defective oxalate transport
1991
Uric Acid and Cardiovascular Risk
2008 Standout
Effect of Restricting Dietary Protein on the Progression of Renal Failure in Patients with Insulin-Dependent Diabetes Mellitus
1991
Fewer nephrons at birth: A missing link in the etiology of essential hypertension?
1995
Maternal and child undernutrition: consequences for adult health and human capital
2008 Standout
Appropriate Blood Pressure Control in NIDDM (ABCD) Trial
1996
Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria
1992
The Modification of Diet in Renal Disease Study
1989
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects
1994
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
2002
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
1994 Standout
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
1993 Standout
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Renal structure and hypertension in autosomal dominant polycystic kidney disease
1990
A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones
1993 Standout
Long-Term Complications of Diabetes Mellitus
1993 Standout
Angiotensin Converting Enzyme Inhibitors and Progressive Renal Insufficiency
1989
Autosomal Dominant Polycystic Kidney Disease—More Than a Renal Disease
1990
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study
1996
Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency
1991
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
The Hallmarks of Aging
2013 Standout
Prevalence of Chronic Kidney Disease in the United States
2007 Standout
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Chronic Kidney Disease
2016 Standout
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
Role of YAP/TAZ in mechanotransduction
2011 StandoutNature
Renal vascular effects of antihypertensive therapy in uninephrectomized SHR
1989
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Assessing the progression of renal disease in clinical studies
1991
Diabetes mellitus and hypertension.
1992
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.
1984
Predictors of an increased risk of future hypertension in Utah. A screening analysis.
1991
Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney.
1996 StandoutNobel
Low protein diets for chronic kidney disease in non diabetic adults
2009
The Role of Hemodynamic Factors in the Initiation and Progression of Renal Disease
1985
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
The Effect of a Keto Acid–Amino Acid Supplement to a Restricted Diet on the Progression of Chronic Renal Failure
1984
Angiotensin-Converting Enzyme Inhibition and Renal Protection
1993
Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
1993
Comparative Study of the Effect of ACE-Inhibitors and Other Antihypertensive Agents on Proteinuria in Diabetic Patients
1994
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease
1983
PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
1996 StandoutScience
Adult Hypertension and Kidney Disease
2006
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
1985 Standout
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
1984
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
2006
Controlled low protein diets in chronic renal insufficiency: meta-analysis.
1992
Long-term Effects of Antihypertensive Agents on Proteinuria and Renal Function
1995
Nephron adaptation to renal injury or ablation
1985
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
The amazing osteocyte
2010 Standout
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
2000 StandoutScience
Measurement of renal function in chronic renal disease
1990
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
1986
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
1984 Standout
Works of E. Valvo being referenced
[Clinico-morphological correlations in uremic osteodystrophy of patients with conservative and hemodialytic treatment with special regard to the ultrastructure].
1975
Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function
1990
Captopril in patients with type II diabetes and renal insufficiency: Systemic and renal hemodynamic alterations
1988
Hemodynamic, Renal, and Humoral Effects of the Calcium Entry Blocker Nicardipine and Converting Enzyme Inhibitor Captopril in Hypertensive Type II Diabetic Patients with Nephropathy
1989
Systemic and renal effects of chronic angiotensin converting enzyme inhibition with captopril in hypertensive diabetic patients
1989
Angiotensin converting enzyme inhibition in normotensive type II diabetics with persistent mild proteinuria
1989
Angiotensin converting enzyme inhibition with a low dose of enalapril in normotensive diabetics with persistent proteinuria
1988
Comparative Effects of Enalapril, Atenolol and Chlorthalidone on Blood Pressure and Kidney Function of Diabetic Patients Affected by Arterial Hypertension and Persistent Proteinuria
1991
Persistent albuminuria in normotensive non-insulin-dependent (type II) diabetic patients: comparative effects of angiotensin-converting enzyme inhibitors and β-adrenoceptor blockers
1992
Clinical Features of Patients with Solitary Kidneys
1986
<sup>125</sup>I-Iothalamate and Creatinine Clearances in Patients with Chronic Renal Disease
1979
Alterations in renal tubular sodium and water transport in polycystic kidney disease.
1975
Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure.
1983
Renal Acidification Defects in Patients with Recurrent Calcium Nephrolithiasis
1985
Hypertension of Polycystic Kidney Disease: Mechanisms and Hemodynamic Alterations
1985
Renal Handling of Phosphate in Patients with Primary and Secondary Hypertension
1986
Effects of dietary protein and phosphorus restriction on the progression of early renal failure
1982
Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet
1985